Engage Media Server from Radisys Complements the Kontron Transportation Product Portfolio for Mission Critical Services
Radisys® Corporation, a global leader of open telecom solutions, announced that Kontron Transportation, a global leading supplier of dedicated end-to-end communication solutions for mission-critical networks, has selected Radisys’ Engage Media Server to complement its in-house mission critical (MCX) product suite. The Radisys solution provides a comprehensive and seamless media management capability that will streamline Kontron Transportation’s operations and drive efficiency while ensuring secure and reliable audio transmission between railway dispatchers and train operators.
Radisys’ Engage Media Server will support unique call handling requirements for Kontron Transportation, delivering software that is compatible with the Kontron Transportation network functions virtualization infrastructure (NFVi). Radisys also provides telco-grade customer support to help Kontron Transportation meet its customers’ stringent service availability demands.
“Kontron Transportation is committed to developing a highly secure next-generation railway mobile communication system that will help infrastructure managers to support existing and enable new applications on their journey to the digital transformation of the rail system. Radisys’ industry-leading media server, together with its comprehensive professional services, will complement Kontron’s development of mission-critical communication solutions for the transportation industry, which requires advanced media processing capabilities to ensure real-time communication applications.” Michael Mikulandra, Head of Products, Kontron Transportation
“We are pleased that Kontron Transportation chose Radisys to help enable next-generation critical communications services with our innovative, scalable and interoperable advanced media processing capabilities. This demonstrates the flexibility of Radisys technology to serve a wide range of public and private network applications in scale and with the reliability demanded in mission-critical applications.” Al Balasco, Senior Vice President & Head of Media, Core and Applications, Radisys
Meet with Radisys at MWC Barcelona
To learn more about Radisys' Engage Media Server and the entire Engage Digital Platform at MWC Barcelona 2023, visit Stand 5B81 or contact open@radisys.com to schedule a meeting with Radisys’ media server experts.
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio, from digital endpoints, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com.
About Kontron Transportation
Kontron Transportation is a global leading supplier of dedicated end-to-end communication solutions for mission critical networks that offers tailor made solutions to support its customers with their communication challenges. The company’s focus is to produce, transport and process voice, data and video information reliably and securely in an efficient and sustainable way. The core product portfolio includes GSM-Railways, FRMCS (future railway mobile communication system), MCx (mission-critical over public networks), 4G/5G public network solutions and IIoT solutions focusing on data processing. Main customers are railways and public transport operators all over Europe. Kontron Transportation drives the evolution into the next generation of broadband solutions for mission-critical networks, for instance as an associated member of the European research initiative Shift2Rail. The company has more than 450 employees, 10 sites all over Europe and is headquartered in Vienna. For more information, visit www.kontron.com/ktrdn.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230301006069/en/
Contact information
Nereus for Radisys
Matt Baxter, +1-503-619-0505
radisys@nereus-worldwide.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nine-Time Emmy Winner, Eric Black, Named Edgio’s CTO/General Manager of Media27.3.2023 15:05:00 CEST | Press release
Edgio, Inc. (Nasdaq: EGIO), the platform of choice for speed, security and simplicity at the edge, today announced it has appointed Eric Black as CTO/General Manager, Media. Having been at the forefront of digital video and live event streaming with NBC Universal for more than twenty years, Black joins Edgio to lead the company’s growth in delivering the highest quality linear, live and on-demand video experiences, to every device worldwide. Prior to joining Edgio, Black led NBC Universal’s media technology strategy across a host of digital properties during pivotal moments in the evolution of live streaming. He managed the first-ever live stream of a Super Bowl in 2010, delivered six Olympic Games (including the Rio 2016 Olympic Games, the largest digital event in history at the time), 2018 FIFA World Cup, and Presidential debates. He also guided the team that launched NBC Universal’s Peacock in 2020. The systems built by Black have focused on both high concurrent traffic and scale, a
ASM Global Unveils Ambitious Plan Transforming Its Global Venue Portfolio Into World’s Most Sustainable Collection27.3.2023 15:00:00 CEST | Press release
ASM Global, through its corporate social responsibility platform, ASM Global Acts, and in partnership with Honeycomb Strategies, has announced a dramatic plan—the most aggressive in the live entertainment industry—to convert its portfolio into the most sustainable venues on Earth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005195/en/ Colorado Convention Center / Photo courtesy of ASM Global Beginning this year ASM Global will dedicate its full resources to achieving measurable results throughout its businesses using the most comprehensive tracking system in the venue space—intended to reflect that scale and create substantial collective impact on every continent it operates. The company working with its client partners already boasts the largest collection of certified green venues with over 40 and growing throughout the portfolio. In making the announcement, ASM Global President and CEO Ron Bension said, “Our curr
Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO ® (avelumab)27.3.2023 14:00:00 CEST | Press release
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer. “On behalf of Merck, I’d like to thank Pfizer for their partnership and collaboration over the last nine years, and for the role they have played in the success of BAVENCIO,” said Belén Garijo, Chair of the Executive Board and CEO of Merck. “Our joint efforts have delivered meaningful therapeutic value to patients around the world who are living with cancer. This has been an incredible journey for us, and thanks to Pfizer’s partnership we are now very well positioned to continue to deliver this therapy to patients in need.” “Our alliance with Merck allowed us to combine our complementary strengths to develop and launch BAVENCIO to help meet the needs of people with cancer globally,” said Dr. Albert Bourla,
Ecoppia Expands its Global Presence with 4 New Projects in Spain and Chile with Matrix Renewables27.3.2023 14:00:00 CEST | Press release
Ecoppia, world’s leader in robotic cleaning solutions has announced an agreement to deploy its robotic solutions in 4 projects developed by Matrix Renewables, the TPG Rise-backed global renewable energy platform. This collaboration will mark Ecoppia’s first project in the Spanish region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005227/en/ Ecoppia H4 Autonomous Robotic Cleaning Solution (Photo: Business Wire) Ecoppia will deploy two robotic models at these PV sites – the Ecoppia H4 and the Ecoppia T4. Both robots are water-free and perform highly efficient cleaning while proven to be fully safe on the modules and structure. Ecoppia will also provide the operations and maintenance (O&M) to the robotics fleet for the projects’ lifetime. The expected total revenues from these projects during their lifespan is estimated at around $13M USD, of which $3.9M against the systems delivery and installation. This announcement
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes27.3.2023 14:00:00 CEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex’s hypoimmune cell therapies for type 1 diabetes (T1D). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005339/en/ “We have multiple programs in our T1D portfolio including VX-880 and VX-264, which are in the clinic, as well as our hypoimmune program, in preclinical development,” said Bastiano Sanna, Ph.D., Executive Vice President and Chief of Cell and Genetic Therapies at Vertex. “Having successfully demonstrated clinical proof of concept in T1D in our VX-880 program, we are excited to deepen our relationship with CRISPR Therapeutics with this agreement, which will allow us to further accelerate our goal of generating fully dif